• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Vincent Bernadette N

    12/3/24 9:39:23 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care
    Get the next $ICU alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Vincent Bernadette N

    (Last) (First) (Middle)
    C/O SEASTAR MEDICAL HOLDING CORPORATION
    3513 BRIGHTON BLVD., SUITE 410

    (Street)
    DENVER CO 80216

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    06/04/2024
    3. Issuer Name and Ticker or Trading Symbol
    SeaStar Medical Holding Corp [ ICU ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    No securities are beneficially owned.
    /s/ David Green, as attorney-in-fact 12/03/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ICU alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ICU

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ICU
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by SeaStar Medical Holding Corporation

      SCHEDULE 13G - SeaStar Medical Holding Corp (0001831868) (Subject)

      6/27/25 5:08:27 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B4 filed by SeaStar Medical Holding Corporation

      424B4 - SeaStar Medical Holding Corp (0001831868) (Filer)

      6/23/25 9:17:18 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical Holding Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Regulation FD Disclosure, Other Events

      8-K - SeaStar Medical Holding Corp (0001831868) (Filer)

      6/23/25 7:16:17 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Neuman John bought $14,396 worth of shares (40,000 units at $0.36), increasing direct ownership by 100% to 80,000 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      6/27/25 6:00:07 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Director Baird Jennifer A bought $12,815 worth of shares (10,000 units at $1.28) (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      5/22/25 5:40:43 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Chief Medical Officer Chung Kevin bought $5,625 worth of shares (4,500 units at $1.25), increasing direct ownership by 33% to 18,185 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      5/20/25 7:07:35 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SeaStar Medical Reports Update on Nasdaq Listing Status

      DENVER, June 25, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that it has undertaken a series of transactions to ensure compliance with Nasdaq's continued listing standards.   Last year on June 24, 2024, SeaStar Medical received a written notification from Nasdaq's Listing Qualifications Staff that it was not in compliance with the requirement to maintain a minimum market value of listed securities of $35 million as required by Nasdaq Listing Rule 5550(b)(2). After a hearing before the Nasdaq Heari

      6/25/25 8:05:00 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

      DENVER, June 20, 2025 (GLOBE NEWSWIRE) --  SeaStar Medical Holding Corporation (the "Company" or "SeaStar Medical") (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today announced the pricing of a public offering of 6,153,847 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and accompanying Series A warrants to purchase up to 6,153,847 shares of common stock and Series B short-term warrants to purchase up to 6,153,847 shares of common stock, at a combined offering price of $0.65 per share of common stock (or per pre-funded warrant in lieu thereof)

      6/20/25 12:10:04 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

      SAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- The Autonomous Reanimation and Evacuation (AREVA) Research Institute and SeaStar Medical (NASDAQ:ICU) announced today that a new United States Department of Defense (DoD) grant has been awarded to AREVA. The grant is one of four selected out of 160 total submissions by the 2024 Military Burn Research Program (MBRP) and represents cutting-edge research for extracorporeal immunomodulation to reduce inflammation after severe burns, inhalation injury, and septicemia. The grant supports a three-year research study that is scheduled to begin in July 2025 with more than $2 million in DoD funding. The study will explore th

      6/11/25 8:25:00 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Neuman John bought $14,396 worth of shares (40,000 units at $0.36), increasing direct ownership by 100% to 80,000 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      6/27/25 6:00:07 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Director Baird Jennifer A bought $12,815 worth of shares (10,000 units at $1.28) (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      5/22/25 5:40:43 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Chief Medical Officer Chung Kevin bought $5,625 worth of shares (4,500 units at $1.25), increasing direct ownership by 33% to 18,185 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      5/20/25 7:07:35 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by SeaStar Medical Holding Corporation

      SC 13G - SeaStar Medical Holding Corp (0001831868) (Subject)

      11/14/24 5:35:52 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care